Anthem's deal with Aspire Health marks another in a slew of provider purchases by insurers aiming to reduce costs by shifting care away from costly inpatient settings.
Brian Pieninck succeeds Chet Burrell, who announced his retirement from the Baltimore-based insurer in September last year.
NYC Health & Hospitals and UnitedHealthcare are heading to arbitration over $11.5 million in denied inpatient medical claims. Most were for emergency care for patients covered by UnitedHealthcare's Medicaid and Medicare programs.
Providers, advocacy groups and some policymakers are pressing for stronger enforcement of mental health parity laws. But congressional Republicans and Democrats disagree about giving the federal government more enforcement power.
David Cordani doesn't view Cigna as merely a health insurer. The Bloomfield, Conn.-based company, he said, is in the business of delivering "health services." The proposed $54 billion purchase of Express Scripts falls in line with that, he argued.
The quarterly profit—the first Oscar has reported since launching five years ago—signals that the health insurer's strategy of creating narrow networks through partnerships with major brand-name hospital systems may be a winner.
Molina has been putting together a new team of experienced Medicaid executives to help turn the struggling insurance company around.
As insurers begin to file 2019 rates, two trends are emerging: Rate hikes will be steep and vary widely across states and plans, as regulators use different strategies to stabilize individual markets and promote affordability and choice.
Brian Griffin, the CEO of Anthem's new in-house pharmacy benefit manager, IngenioRx, has resigned to head up Diplomat Pharmacy, a specialty pharmacy services provider.
Clover Health, a Medicare Advantage insurer that uses data analytics to care for its members, will provide in-home primary care and genetic testing to its sickest senior patients.
The foundation was created using the proceeds from the sale of the church's not-for-profit health plan, Fidelis Care, to publicly traded Centene Corp. for $3.75 billion.
An insurer uses image of hikers in the mountains to sell health insurance that doesn't cover treatment for mountain climbing injuries, delivering a bit of a mixed message.